Similar articles for PMID: 26208875

Year	Number of Results
2002	1
2005	2
2006	1
2007	2
2008	1
2009	5
2010	2
2011	5
2012	7
2013	5
2014	4
2015	9
2017	1
2019	3
2021	2
2022	3
2023	1
2024	0

1

Foreword: "The PI3-kinase/Akt pathway: From signaling to diseases".

Payrastre B, Cocco L. Payrastre B, et al. Adv Biol Regul. 2015 Sep;59:1-3. doi: 10.1016/j.jbior.2015.07.001. Epub 2015 Jul 18. Adv Biol Regul. 2015. PMID: 26208875 No abstract available.

2

PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: new options for targeted therapy.

Martelli AM, Tabellini G, Ricci F, Evangelisti C, Chiarini F, Bortul R, McCubrey JA, Manzoli FA. Martelli AM, et al. Adv Biol Regul. 2012 Jan;52(1):214-27. doi: 10.1016/j.advenzreg.2011.09.019. Adv Biol Regul. 2012. PMID: 21983557 No abstract available.

3

[Genetic alterations in MAPK and PI3K/Akt signaling pathways and the generation, progression, diagnosis and therapy of thyroid cancer].

Liu B, Kuang A. Liu B, et al. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012 Dec;29(6):1221-5. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012. PMID: 23469561 Review. Chinese.

4

Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.

Bouchard V, Demers MJ, Thibodeau S, Laquerre V, Fujita N, Tsuruo T, Beaulieu JF, Gauthier R, Vézina A, Villeneuve L, Vachon PH. Bouchard V, et al. J Cell Physiol. 2007 Sep;212(3):717-28. doi: 10.1002/jcp.21096. J Cell Physiol. 2007. PMID: 17443665

5

Class IA phosphatidylinositol 3-kinase signaling in non-small cell lung cancer.

Solomon B, Pearson RB. Solomon B, et al. J Thorac Oncol. 2009 Jul;4(7):787-91. doi: 10.1097/JTO.0b013e3181a74dba. J Thorac Oncol. 2009. PMID: 19550242 Free article. Review. No abstract available.

6

PI3K/AKT signaling pathway and cancer: an updated review.

Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. Martini M, et al. Ann Med. 2014 Sep;46(6):372-83. doi: 10.3109/07853890.2014.912836. Epub 2014 Jun 5. Ann Med. 2014. PMID: 24897931 Review.

7

The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer.

Schuurbiers OC, Kaanders JH, van der Heijden HF, Dekhuijzen RP, Oyen WJ, Bussink J. Schuurbiers OC, et al. J Thorac Oncol. 2009 Jun;4(6):761-7. doi: 10.1097/JTO.0b013e3181a1084f. J Thorac Oncol. 2009. PMID: 19404218 Free article. Review.

8

Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).

Hafsi S, Pezzino FM, Candido S, Ligresti G, Spandidos DA, Soua Z, McCubrey JA, Travali S, Libra M. Hafsi S, et al. Int J Oncol. 2012 Mar;40(3):639-44. doi: 10.3892/ijo.2011.1312. Epub 2011 Dec 20. Int J Oncol. 2012. PMID: 22200790 Review.

9

The PI3' kinase pathway in interferon signaling.

Kaur S, Uddin S, Platanias LC. Kaur S, et al. J Interferon Cytokine Res. 2005 Dec;25(12):780-7. doi: 10.1089/jir.2005.25.780. J Interferon Cytokine Res. 2005. PMID: 16375606 Review.

10

Salmonella enteritidis Rck-mediated invasion requires activation of Rac1, which is dependent on the class I PI 3-kinases-Akt signaling pathway.

Mijouin L, Rosselin M, Bottreau E, Pizarro-Cerda J, Cossart P, Velge P, Wiedemann A. Mijouin L, et al. FASEB J. 2012 Apr;26(4):1569-81. doi: 10.1096/fj.11-189647. Epub 2011 Dec 30. FASEB J. 2012. PMID: 22210834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

48 results

Results by year